FDA Resists Push For Longer Rulemaking Route On Lab-Developed Tests
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to get a proposed regulatory framework for lab-developed tests out the door within a matter of months, but lab groups and other stakeholders are saying: slow down
You may also be interested in...
Regulatory News In Brief
Two a-fib devices go to panel
Regulatory News In Brief
Two a-fib devices go to panel
Senate Bill In The Works For Laboratory-Developed Tests
Sen. Orrin Hatch, R-Utah, is developing a bill that would create a new pre-market review process for laboratory-developed tests, even as FDA plans to pursue such oversight without legislation.